I agree that this site is using cookies. You can find further informations here.
X
Chisamore, Timothy M.
~ 0  results:
Search for persons X
?
1

Industry payments to US physicians for cancer therapeutics:..:

Meyers, Daniel E. ; Chisamore, Timothy M. ; McInnes, Matthew D.F....
Journal of Cancer Policy.  28 (2021)  - p. 100283 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Trends in drug revenue among major pharmaceutical companies..:

Meyers, Daniel E. ; Meyers, Benjamin S. ; Chisamore, Timothy M....
Cancer.  128 (2021)  2 - p. 311-316 , 2021
Link: https://doi.org/10.1002/..
 
?
3

Trends in drug revenue among major pharmaceutical companies..:

Meyers, Daniel E ; Meyers, Benjamin S ; Chisamore, Timothy M...
qt4r19p6zg.  , 2022
Link: https://escholarship.org..
 
?
4

Industry payments to US physicians for cancer therapeutics:..:

Meyers, Daniel E ; Chisamore, Timothy M ; McInnes, Matthew DF...
qt94h4q3sz.  , 2021
Link: https://escholarship.org..
 
?
5

Industry Relationships With Medical Oncologists: Who Are th..:

Wright, Kristin ; Meyers, Daniel E ; Chisamore, Timothy M...
qt0x77g8db.  , 2022
Link: https://escholarship.org..
 
?
6

CORE1: Phase 2 single arm study of CG0070 combined with pem..:

Li, R. ; Steinberg, G.S. ; Uchio, E.U....
European Urology.  83 (2023)  - p. S603 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Characterizing the Effects of Extreme Cold Using Real-time ..:

VanStone, Nancy ; van Dijk, Adam ; Chisamore, Timothy...
Public Health Reports (1974-).  132 (2017)  1S - p. 48S-52S , 2017
Link: https://www.jstor.org/st..
 
?
8

Characterizing the Effects of Extreme Cold Using Real-time ..:

VanStone, Nancy ; van Dijk, Adam ; Chisamore, Timothy...
Public Health Reports.  132 (2017)  1_suppl - p. 48S-52S , 2017
Link: https://doi.org/10.1177/..
 
?
9

60P Sacituzumab govitecan (SG) + pembrolizumab (pembro) in ..:

Cappuzzo, F. ; Patel, J. ; Cho, B.C....
ESMO Open.  9 (2024)  - p. 102639 , 2024
Link: https://doi.org/10.1016/..
 
?
10

391P Phase II results of the porcupine (PORCN) inhibitor za..:

Bridgewater, J.A. ; Chantrill, L. ; Gillmore, R....
Annals of Oncology.  35 (2024)  - p. S157 , 2024
Link: https://doi.org/10.1016/..
 
?
11

OA05.04 Sacituzumab Govitecan + Pembrolizumab in 1L Metasta..:

Cho, B.C. ; Dols, M.C. ; Reyes Cabanillas, R....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S54 , 2023
Link: https://doi.org/10.1016/..
 
?
12

187P Phase I/II study of the oral CCR4 antagonist, FLX475, ..:

Lin, C-C. ; Kim, T.M. ; Desai, P....
Immuno-Oncology and Technology.  16 (2022)  - p. 100299 , 2022
Link: https://doi.org/10.1016/..
 
?
13

161P A phase Ib study to evaluate IK-007 in combination wit..:

Tolcher, A.W. ; Spigel, D.R. ; Leal, A.D....
Immuno-Oncology and Technology.  16 (2022)  - p. 100273 , 2022
Link: https://doi.org/10.1016/..
 
?
14

MA13.07 TROPION-Lung02: Initial Results for Datopotamab Der..:

Levy, B. ; Paz-Ares, L. ; Rixe, O....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S91 , 2022
Link: https://doi.org/10.1016/..
 
?
15

A phase 2 study of futibatinib plus pembrolizumab in patien..:

Sonpavde, G. ; Koshkin, V.S. ; Hwang, C....
European Urology Open Science.  33 (2021)  - p. S383-S384 , 2021
Link: https://doi.org/10.1016/..
 
1-15